Authors : Roshan Poudel; Birendra Kumar Yadav; Chaitanya Darshan Bhattrai; Priya Yadav; Animesh Dhungana; Bibek Joshi; Abhishek Jha; Shashi Kant

Volume/Issue : Volume 9 - 2024, Issue 8 - August

Google Scholar : https://tinyurl.com/2jvmjkdt

Scribd : https://tinyurl.com/2e9rcwf2

DOI : https://doi.org/10.38124/ijisrt/IJISRT24AUG584

Abstract : Introduction: Neonatal jaundice is a common cause of admission in the neonatal period. Early diagnosis and treatment of neonatal jaundice prevent the bilirubin encephalopathy. There are various methods for the estimation of neonatal jaundice. Clinical assessment of neonatal jaundice can aid in the diagnosis of neonatal jaundice in low-resource settings and refer to the higher center for those who require treatment. This study aims to understand the relation between clinical assessment of jaundice and total serum bilirubin in neonates and to know the risk factors of neonatal jaundice.  Methods: The Clinical assessment of jaundice by Kramers scale can be used to assess the level of jaundice and know the progression of jaundice.  Results: This shows a significant positive relation between clinical assessment of jaundice and serum bilirubin level.  Conclusions: The study findings showed that clinical assessment of jaundice was comparable with the serum bilirubin. Clinical assessment of jaundice by Kramer‟ 's scale can be used to assess the level of jaundice and know the progression of jaundice.

Keywords : Bilirubin, Jaundice, Kramers Scale, Neonate.

References :

1. Gómez M, Bielza C, Fernández del Pozo JA, Ríos-Insua S. A Graphical DecisionTheoretic Model for Neonatal Jaundice. Medical Decision Making. 2007;27(3):250-65.
2. Burke BL, Robbins JM, Bird TM, Hobbs CA, Nesmith C, Tilford JM. Trends in hospitalizations for neonatal jaundice and kernicterus in the United States, 1988-2005. Pediatrics. 2009 Feb;123(2):524-32.
3. Young Infants Clinical Signs Study Group. Clinical signs that predict severe illness in children under age 2 months: a multicentre study. Lancet. 2008 Jan 12;371(9607):13542.
4. Berkwitt A, Osborn R, Grossman M. The Utility of Inpatient Rebound Bilirubin Levels in Infants Readmitted After Birth Hospitalization for Hyperbilirubinemia. Hosp Pediatr. 2014;5(2):1671-9.
5. Lucia MP, Camila RM, Cloherty JP. Neonatal hyberbilirubinemia. In: Cloherty JP, Eichenwald EC, Hansen AR, Stark AR, editors. Manual of neonatal care, 7th ed. Lippincott Williams and Wilkins a Wolters Kluwer business. 2008;304-39.
6. Sarici SU, Serdar MA, Korkmaz A, et al. Incidence, course, and prediction of hyperbilirubinemia in near-term and term newborns. Pediatrics 2004;113(4):775-80.
7. Seidman DS, Ergaz Z, Paz I, et al. Predicting the risk of jaundice in full-term healthy newborns: a prospective population-based study. J Perinatol 1999;19(8 Pt 1):564-7.
8. Huang MJ, Kua KE, Teng HC et al. Risk factors for severe hyperbilirubinemia in neonates. Pediatr Res. 2004;56(5):682-9.
9. Ullah S, Rahman K, Hedayati M. Hyperbilirubinemia in Neonates: Types, Causes, Clinical Examinations, Preventive Measures and Treatments: A Narrative Review Article. Iran J Public Health. 2016;45(5):558-68.
10. Watchko JF. Neonatal hyperbilirubinemia: what are the risks? N Engl J Med 2006;354(18):1947–9.
11. Olusanya BO, Teeple S, Kassebaum NJ. The Contribution of Neonatal Jaundice to Global Child Mortality: Findings From the GBD 2016 Study. Pediatrics. 2018;141(2):e20171471.
12. Slusher TM, Zamora TG, Appiah D, et al. Burden of severe neonatal jaundice: a systematic review and meta-analysis. BMJ Paediatr Open. 2017;1(1):e000105.
13. Brown AK, Damus K, Kim MH et al. Factors relating to readmission of term and near-term neonates in the first- two weeks of life. Early discharge survey group of the Health Professional Advisory Board of the Greater NY Chapter of the March of Dimes. J Perinat. Med 1999;27(4):263-75.
14. Madan A, James RM, Stevens on DK. Neonatal Hyperbilirubinemia. In: Taeusch HW, Ballard RA, Gleason CA. th Avery's diseases of the newborn. 8 ed. Philadelphia: Elsevier Saunders;2004;1226-56.
15. Maisels MJ. Noninvasive measurements of bilirubin. Pediatrics. 2012;129(4):779-781.
16. Kramer LI. Advancement of dermal icterus in the jaundiced newborn. Am J Dis Child 1969;118:454-8.
17. Practice parameter: management of hyperbilirubinemia in the healthy term newborn. American Academy of Pediatrics. Provisional Committee for Quality Improvement and Subcommittee on Hyperbilirubinemia. Pediatrics. 1994 Oct;94(4 Pt 1):558-65. Erratum in: Pediatrics 1995 Mar;95(3):458-61.
18. Mojtahedi SY, Izadi A, Seirafi G, Khedmat L, Tavakolizadeh R. Risk Factors Associated with Neonatal Jaundice: A Cross-Sectional Study from Iran. Open Access Maced J Med Sci. 2018;6(8):1387-93.
19. Najib KS, Saki F, Hemmati F, Inaloo S. Incidence, risk factors and causes of severe neonatal hyperbilirubinemia in the South of Iran (fars province). Iran Red Crescent Med J. 2013;15(3):260-3.
20. Koosha A, Rafizadeh B. Evaluation of neonatal indirect hyperbilirubinemia at Zanjan Province of Iran in 2001-2003: prevalence of glucose-6-phosphate dehydrogenase deficiency. Singapore Med J. 2007;48(5):424-8.
21. Varughese PM. Kramer's scale or transcutaneous bilirubinometry: the ideal choice of a pediatrician? can we trust our eyes? Int J Contemp Pediatr 2019;6:1794-801.
22. Aprillia Z, Gayatri D, Waluyanti FT. Sensitivity, Specificity, and Accuracy of Kramer Examination of Neonatal Jaundice: Comparison with Total Bilirubin Serum. Compr Child Adolesc Nurs. 2017;40(sup1):88-94.
23. Szabo P, Wolf M, Ulrich Bucher HU, Haenesse D, FauchY¨ re JC, Arlettaz R. Assessment of jaundice in preterm neonates: comparison between clinical assessment, two transcutaneous bilirubin meters and serum bilirubin values. Acta Paediatr 2004;93:1491-5.
24. Hatzenbuehler L, Zaidi AKM, Sundar S, Sultana S, Abbasi F, Rizvi A, et al. Validity of neonatal jaundice evaluation by primary health-care workers and physicians in Karachi, Pakistan. J Perinatol Off J Calif Perinat Assoc 2010;30(9):616–21.
25. Dionis, I., Chillo, O., Bwire, G.M. et al. Reliability of visual assessment of neonatal jaundice among neonates of black descent: a cross-sectional study from Tanzania. BMC Pediatr. 2021; 21: 383.
26. Mumtaz S, Shafiq MF, Khan KA, Hussain M, Rahman A, Shafiq S. Diagnostic Accuracy of Kramer Visual Assessment of Jaundice in Term Neonates Taking Total Serum Bilirubin Levels as the Gold Standard. Pak Armed Forces Med J 2022; 72(6): 1953-6.
27. Shaikh S, Das C, Kumar J, Chand S, Hotwani S, et al. Validity of Kramer Scale in Neonatal Hyperbilirubinemia. Austin J Gastroenterol. 2023; 10(1): 1120.
28. Moyer VA, Ahn C, Sneed S. Accuracy of clinical judgment in neonatal jaundice. Arch Pediatr Adolesc Med 2000;154(4):391-4.